Moderna entered into a collaboration/licensing agreement Thursday with oncology-focused CytomX to discover and develop conditionally activated mRNA therapies for cancer.
Tag Archive for: OriCiro Genomics
Moderna Inc. on Wednesday agreed to buy Japan-based OriCiro Genomics for $85 million to boost the U.S. drugmaker’s messenger RNA (mRNA) manufacturing capabilities.